Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Imuran Dosing in Crohn's Disease Study

ClinicalTrials.gov ID: NCT00113503

Public ClinicalTrials.gov record NCT00113503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-site Trial of Azathioprine Dosing in Crohn's Disease

Study identification

NCT ID
NCT00113503
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Enrollment
50 participants

Conditions and interventions

Interventions

  • Azathioprine weight-based dose Drug
  • Azathioprine individualised dose Drug

Drug

Eligibility (public fields only)

Age range
10 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Nov 30, 2007
Completion
Nov 30, 2007
Last update posted
Oct 5, 2017

2005 – 2007

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048
Atlanta Gastroenterology Associates, LLC Atlanta Georgia 30342
University of Chicago Pediatric Gastroenterology Chicago Illinois 60637
University of Chicago Chicago Illinois 60637
Johns Hopkins University Baltimore Maryland 21287
Duluth Clinic Duluth Minnesota 55805
Mayo Clinic Rochester Minnesota 55905
Long Island Clinical Research Assoc. Great Neck New York 11021
Mt. Sinai Medical Center New York New York 10029
University of North Carolina Chapel Hill Chapel Hill North Carolina 27514
Cincinnati Children's Hospital Cincinnati Ohio 45229
University of Pittsburgh Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00113503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00113503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →